Radiation protection devices and radiopharmaceutical delivery systems containing them

By using a locking structure with wedge-shaped protrusions and grooves, and a sloping inner wall design, the problem of fixing V-shaped bottles of different volumes is solved, enabling rapid and safe fixing of radiopharmaceutical bottles and reducing radiation risks and resource waste.

CN224958440UActive Publication Date: 2026-11-10JIANGSU MEDNOVO MEDICAL GRP CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202522528379.X
Authority / Receiving Office
CN · China
Patent Type
Utility models(China)
Current Assignee / Owner
Filing Date
2025-11-28
Publication Date
2026-11-10
Estimated Expiration
2035-11-28

AI Technical Summary

Technical Problem

Existing shielding devices can only secure V-shaped bottles of one volume, resulting in the need for multiple shielding devices for V-shaped bottles of different volumes, leading to resource waste and increased costs. At the same time, the fragile V-shaped bottles are prone to leakage of radioactive nuclides due to shaking during transfer.

Method used

A radiation protection device was designed, which uses the cooperation of wedge-shaped protrusions and sliding grooves to lock the cover and the shielding body. The inner wall of the lower end of the rod is sloping, which can quickly lock and fix radiopharmaceutical product bottles of different volumes to prevent shaking.

Benefits of technology

It enables non-destructive and rapid fixation of radiopharmaceutical product vials, reducing radiation exposure for medical personnel during fixation and preventing vial breakage and radionuclide leakage during transfer.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN224958440U_ABST
    Figure CN224958440U_ABST
Patent Text Reader

Abstract

This utility model relates to the field of medical devices, providing a radiation protection device and a radiopharmaceutical infusion system including the radiation protection device. The radiation protection device includes a cap and a shielding body. The cap includes a cap portion and a rod portion extending downward from the cap portion. The rod portion has an inner cavity suitable for receiving the neck and part of the shoulder of a radiopharmaceutical product vial, and the lower end of the rod portion has a sloping inner wall. The shielding body includes a joint portion that engages with the cap and a receiving portion for receiving the radiopharmaceutical product vial. The joint portion has a channel extending in the height direction, and the channel is configured to allow the radiopharmaceutical product vial and the rod portion to pass through and enter the receiving portion. One of the cap and the shielding body has a wedge-shaped protrusion, and the other has a groove suitable for engaging the wedge-shaped protrusion. When the cap and the shielding body are tightened by engaging the wedge-shaped protrusion and the groove, the sloping inner wall abuts against the shoulder of the radiopharmaceutical product vial. The radiopharmaceutical product vial can be secured without damage and quickly.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This utility model relates to the field of medical devices, and in particular to a radiation protection device and a radiopharmaceutical infusion system including the radiation protection device. Background Technology

[0002] Radiopharmaceuticals are an important component of nuclear medicine, widely used in cancer diagnosis and treatment. A common type of radiopharmaceutical is the radioactive microsphere, an insoluble material, which is currently commercially available from several companies. Radioactive microspheres can be used to treat inoperable tumors, and clinical data indicates that this method is quite effective. The delivery of radioactive microspheres to the body requires the use of water for injection and contrast agents.

[0003] The amount of radioactive microsphere solution required for infusion is determined based on the severity of the patient's condition, generally in 2 ml or 5 ml increments. Different volumes of radioactive microsphere solution require loading into radiopharmaceutical vials of different volumes (usually V-shaped vials), necessitating multiple sizes of vials. Typically, a 5 ml V-shaped vial holds 2 ml of the microsphere solution; a 10 ml V-shaped vial holds 5 ml. Since V-shaped vials are generally made of glass and are fragile, and the radioactive microsphere solution needs to be transferred within the hospital, it is crucial to prevent the vials from breaking due to shaking within the shielding device, which could lead to radionuclide leakage. Because existing shielding devices are only suitable for securing one type of V-shaped vial, and different volumes have different outer diameters and heights, multiple additional shielding devices are required to secure these different volumes, resulting in resource waste and increased costs. Utility Model Content

[0004] To address the aforementioned technical problems, this disclosure provides a radiation protection device and a radiopharmaceutical delivery system including the radiation protection device, which can secure radiopharmaceutical product bottles non-destructively and quickly, thereby reducing radiation exposure for medical personnel during the process of securing the radiopharmaceutical product bottles to the radiation protection device.

[0005] The first aspect of this disclosure discloses a radiation shielding device adapted to a radiopharmaceutical product vial in a radiopharmaceutical infusion system. The vial includes a neck, shoulder, and body connected sequentially from top to bottom in its height direction. The radiation shielding device includes a cap and a shielding body. The cap includes a crown and a rod extending downward from the crown. The lateral dimension of the crown is greater than that of the rod. The rod has an inner cavity adapted to accommodate the neck and part of the shoulder of the radiopharmaceutical product vial, and its lower end has a sloping inner wall. The shielding body includes a joint that engages with the cap and a receiving portion for accommodating the radiopharmaceutical product vial. The joint has a channel extending in the height direction, configured to allow the radiopharmaceutical product vial and the rod to pass through and enter the receiving portion. The cap and the shielding body each have a wedge-shaped protrusion and a groove suitable for engaging the wedge-shaped protrusion. The wedge-shaped protrusion or groove on the cap is located on the outer periphery of the rod, and the wedge-shaped protrusion or groove on the shielding body is located at the joint. When the radiopharmaceutical product bottle is placed in the receiving part and the cap and the shielding body are tightened by the wedge-shaped protrusion and the groove, the sloping inner wall abuts against the shoulder of the radiopharmaceutical product bottle.

[0006] Furthermore, the wedge-shaped protrusion has an inclined upper surface, which is inclined downward along the tightening direction; the slide has an inclined mating surface, which is adapted to mate with the upper surface of the wedge-shaped protrusion such that when the wedge-shaped protrusion and the slide are tightened, the mating surface at least partially abuts against the upper surface of the wedge-shaped protrusion.

[0007] In some embodiments, a wedge-shaped protrusion is disposed on the outer wall of the cover and connected to the outer side of the rod, and a groove is disposed on the inner side wall of the joint of the shielding body.

[0008] In some embodiments, the angle between the radial extension line arranged from top to bottom on the upper surface of the wedge-shaped protrusion and the horizontal plane transitions from α° to -α°, where α° is greater than 0°; wherein, the radial extension line refers to the boundary line between the radial tangent of the cover and the upper surface of the wedge-shaped protrusion, and the mating surface is configured to coincide with the upper surface of the wedge-shaped protrusion.

[0009] In some embodiments, the wedge-shaped protrusions are configured as two pieces, which are evenly spaced apart circumferentially; the joint is provided with two notches communicating with the channel of the joint, which are symmetrically arranged; and two grooves are configured, which are respectively located between the two notches; wherein each notch is configured to allow one wedge-shaped protrusion to pass through.

[0010] In some embodiments, the joint includes two wedge-shaped blocks disposed on its inner sidewall, the lower surface of the wedge-shaped blocks being the mating surface of the groove, and the two wedge-shaped blocks forming a channel in the radial direction; the radial dimension of the rod is adapted to the radial dimension of the channel and the receiving portion, such that the outer sidewall of the rod fits against the wedge-shaped blocks and the inner sidewall of the receiving portion.

[0011] In some embodiments, the height of the stroke of the wedge-shaped protrusion and the groove is greater than or equal to the height difference between two radiopharmaceutical product vials of different height specifications.

[0012] In some embodiments, the radiopharmaceutical infusion system includes a first needle body and a second needle body; the cap is provided with a first puncture hole and a second puncture hole, the first puncture hole being adapted to guide the first needle body into the radiopharmaceutical product vial, and the second puncture hole being adapted to guide the second needle body into the radiopharmaceutical product vial; wherein, the first needle body is used to deliver the drug in the radiopharmaceutical product vial to the patient's lesion site, and the second needle body is used to inject gas or water for injection into the radiopharmaceutical product vial.

[0013] In some embodiments, both the first puncture hole and the second puncture hole are provided on the cap, the first puncture hole is located at the center of the cap, and the distance between the first puncture hole and the second puncture hole is ≥2mm.

[0014] The second aspect of this disclosure discloses a radiopharmaceutical delivery system, including an infusion tank, a flow channel, a three-way valve disposed on the flow channel, a first needle body, a second needle body, and a radiation shielding device as described in the first aspect. The first needle body and the second needle body are in fluid communication with a radiopharmaceutical product vial. The radiation shielding device and the three-way valve are both disposed within the infusion tank. The flow channel includes a first conduit, a second conduit, a third conduit, and a fourth conduit. The three ends of the three-way valve are respectively connected to the first conduit, the second conduit, and the third conduit. The fourth conduit is in fluid communication with the radiopharmaceutical product vial through the second needle body. The other end of the first conduit is connected to the human body. The second conduit is used to deliver water for injection or contrast agent to the human body. The other end of the third conduit is connected to the radiopharmaceutical product vial through the first needle body. The fourth conduit is used to inject gas or water for injection into the radiopharmaceutical product vial. The three-way valve can be operated to selectively connect any two of the first, second, and third conduits.

[0015] The features and advantages of this disclosure include:

[0016] On the one hand, because the radiation shielding device locks the cap and the shielding body together through the cooperation of wedge-shaped protrusions and wedge-shaped stops, the locking process is relatively effortless and can be locked at any position throughout the entire stroke. Furthermore, compared to threaded structures, it allows for faster locking. On the other hand, because the lower inner wall of the cap's rod is constructed in a sloping shape, when the radiopharmaceutical vial is placed in the receiving section and the cap and shielding body are tightened via the wedge-shaped protrusions and grooves, the sloping inner wall of the rod abuts against the shoulder of the radiopharmaceutical vial. Therefore, it prevents the vial from shaking and breaking during transfer within the radiation shielding device. In summary, the radiation shielding device of this disclosure can secure radiopharmaceutical vials non-destructively and quickly, reducing radiation exposure for medical personnel during the process of securing the vials to the radiation shielding device. Attached Figure Description

[0017] To more clearly illustrate the technical solutions in the embodiments of this disclosure, the accompanying drawings used in the description of the embodiments will be briefly introduced below. Obviously, the accompanying drawings described below are only some embodiments of this disclosure. For those skilled in the art, other drawings can be obtained based on these drawings without creative effort.

[0018] Figure 1 A schematic diagram of the infusion system of this disclosure is shown;

[0019] Figure 2 A three-dimensional structural schematic diagram of the infusion system of this disclosure is shown;

[0020] Figure 3 It shows Figure 2 A schematic diagram of the internal structure of the infusion box in the middle;

[0021] Figure 4 An explosion diagram of the radiation protection device, its operating lever, limit seat, support seat, and three-way valve is shown.

[0022] Figure 5 A three-dimensional structural schematic diagram of one embodiment of the radiation protection device is shown;

[0023] Figure 6 It shows Figure 5 A schematic diagram of an explosion of a radiation protection device;

[0024] Figure 7 It shows Figure 6 A cross-sectional schematic diagram of the shielding body in the diagram;

[0025] Figure 8 It shows Figure 5 A cross-sectional view of the radiation shielding device when a 5ml V-shaped bottle is loaded.

[0026] Figure 9 It shows Figure 5 A cross-sectional view of the radiation shielding device when a 10ml V-shaped bottle is loaded.

[0027] Figure 10 A three-dimensional structural schematic diagram of another embodiment of the radiation protection device is shown;

[0028] Figure 11 It shows Figure 10 A schematic diagram of an explosion of a radiation protection device;

[0029] Figure 12 It shows Figure 11 A cross-sectional schematic diagram of the shielding body and the inner liner;

[0030] Figure 13 It shows Figure 12 An explosion diagram of the shielding body and the inner liner;

[0031] Figure 14 It shows Figure 10 A cross-sectional view of the radiation shielding device in its initial state when loaded with a 5ml V-shaped bottle.

[0032] Figure 15 It shows Figure 10 A cross-sectional view of the radiation shielding device in its locked state when loaded with a 10ml V-shaped bottle;

[0033] Figure 16 It shows Figure 10 A cross-sectional view of the radiation shielding device in its locked state when loaded with a 10ml V-shaped bottle.

[0034] Explanation of reference numerals in the attached figures: 100-Radiation protection device; 10-Cap, 11-Cap part, 112-Stepped hole, 114-Boss, 12-Rod part, 13-Wedge-shaped protrusion, 131-Upper surface, 132-Lower surface, 14-Sloping inner wall, 15-First puncture hole, 16-Second puncture hole; 20-Shielding body, 202-Bottom wall, 21-Joint, 212-Notch, 22-Accommodating part, 224-Inner side wall, 23-Wedge-shaped stop, 231-Mating surface, 24-Slide groove, 248-Limiting surface, 25-Inner liner movable part, 251-Protruding rib, 26-Annular flange, 27-Inner liner, 271-Groove, 272-Rotating shaft, 273-Modible foot, 2731-Fixed end, 2732-Free end, 2733-Rotating shaft hole, 274-Second elastic element, 275-Accommodating groove, 276-Spring hole, 28-First elastic element; 32 - First needle body, 34 - Second needle body; 40 - Radiopharmaceutical product vials, 402 - 5ml V-shaped vials, 404 - 10ml V-shaped vials; 42 - Neck, 44 - Shoulder, 46 - Body; 200 - Radiopharmaceutical infusion system, 201 - First tubing, 202 - Second tubing, 203 - Third tubing, 204 - Fourth tubing, 211 - Three-way valve, 2112 - Knob, 221 - First syringe, 222 - Second syringe, 223 - Third syringe; 240-Infusion tank, 241-Tank cover, 242-First side wall, 2421-First hole, 2424-Three-way valve fixing bracket, 243-Second side wall, 2432-Second hole, 2433-Third hole, 2434-Fourth hole, 2436-Limiting plate, 2438-Limiting groove, 244-Third side wall, 2442-Support base, 2444-Through hole, 245-Fourth side wall, 246-Base plate, 247-Fixing ring; 260-Operating lever, 261-Lever body, 262-Valve core connection part, 263-Limit block, 264-Handle, 265-Baffle. Detailed Implementation

[0035] The technical solutions of the embodiments of this disclosure will be clearly and completely described below with reference to the accompanying drawings. Obviously, the described embodiments are only a part of the embodiments of this disclosure, and not all of them. Based on the embodiments of this disclosure, all other embodiments obtained by those of ordinary skill in the art without creative effort are within the scope of protection of this disclosure.

[0036] See Figures 1 to 4 This disclosure provides a delivery system 200 for insoluble radiopharmaceuticals, comprising a flow channel, a delivery tank 240, and a radiation shield 100. The radiation shield 100 is disposed within the delivery tank 240, and a radiopharmaceutical product vial 40 is placed within the radiation shield 100. The radiopharmaceutical product vial 40 is used to store the insoluble radiopharmaceutical; preferably, the radiopharmaceutical product vial 40 is constructed as a transparent V-shaped vial (conical bottom vial). A three-way valve 211 is provided within the delivery tank 240. Operating the three-way valve 211 selectively connects the radiopharmaceutical product vial 40 to the flow channel, thereby injecting the insoluble radiopharmaceutical into the flow channel. The delivery system 200 is used to deliver insoluble materials to a living organism, which may be a human or other animal. The insoluble radiopharmaceutical may specifically be radioactive microspheres or other insoluble materials used for radiotherapy. The following description uses a human body and radioactive microspheres as examples.

[0037] Specifically, see Figure 1The radiopharmaceutical infusion system 200 includes three syringes, two three-way valves 211, a radiopharmaceutical product vial 40, and flow channels. One three-way valve 211 is located inside the infusion tank 240, and the other three-way valve 211 is located outside the infusion tank 240. The three syringes are designated as a first syringe 221, a second syringe 222, and a third syringe 223. The first syringe 221 is used for injecting water for injection, the second syringe 222 is used for injecting contrast agent, and the third syringe 223 is used for injecting both water for injection and air. The flow channels of the infusion system 200 include a first conduit 201, a second conduit 202, a third conduit 203, and a fourth conduit 204. A three-way valve 211 located inside the infusion tank 240 has three ends connected to a first conduit 201, a second conduit 202, and a third conduit 203, respectively. The other end of the first conduit 201 is connected to the human body, the other end of the second conduit 202 is connected to the three-way valve 211 located outside the infusion tank 240, and the other end of the third conduit 203 is connected to the radiopharmaceutical product vial 40. Operating the three-way valve 211 inside the infusion tank 240 can selectively connect the second conduit 202 to the third conduit 203, thereby venting air from the third conduit 203. Operating the three-way valve 211 inside the infusion tank 240 can also selectively connect the third conduit 203 or the second conduit 202 to the first conduit 201, thereby injecting the radioactive microspheres in the radiopharmaceutical product vial 40 or the medium (water for injection or contrast agent) in the second conduit 202 into the human body. The three-way valve 211, located outside the infusion tank 240, is connected to the first syringe 221, the second syringe 222, and the second tubing 202 at its three ends. By operating the three-way valve 211 located outside the infusion tank 240, the first syringe 221 or the second syringe 222 can be selectively connected to the second tubing 202, thereby allowing water for injection or contrast agent to enter the second tubing 202.

[0038] Optionally, the infusion system 200 further includes a first needle body 32 and a second needle body 34. The first needle body 32 and the second needle body 34 extend through the rubber stopper located in the radiopharmaceutical product vial 40, thereby entering the inner cavity of the radiopharmaceutical product vial 40. The first needle body is used to deliver the drug in the radiopharmaceutical product vial to the patient's lesion site, and the second needle body is used to inject gas or water for injection into the radiopharmaceutical product vial 40.

[0039] In some embodiments, the infusion system 200 further includes an actuator for operating a three-way valve 211 within the infusion tank 240, the actuator being configured as a servo motor coupled to the three-way valve 211. In other embodiments, the actuator may be configured as an operating lever 260, which, when operated, switches the valve core of the three-way valve 211 within the infusion tank 240 between a first position, a second position, and a third position, selectively connecting the third conduit 203 or the second conduit 202 to the first conduit 201, thereby injecting radioactive microspheres from the radiopharmaceutical product vial 40 or media (contrast agent, etc.) from the second conduit 202 into the human body, and connecting the second conduit to the third conduit 203 to expel air from the third conduit 203.

[0040] Specifically, see Figure 2 and Figure 3 The infusion tank 240 includes a cover 241, a base plate 246, and side walls located between the cover 241 and the base plate 246. A fixing ring 247 is provided in the middle of the base plate 246, and the radiation shielding device 100 is placed inside the fixing ring 247. More specifically, the infusion tank 240 is constructed as a cuboid, and the side walls include a first side wall 242, a second side wall 243, a third side wall 244, and a fourth side wall 245. In a top view, the first side wall 242, the third side wall 244, the second side wall 243, and the fourth side wall 245 are arranged counterclockwise, i.e., the first side wall 242 and the second side wall 243 are arranged opposite each other, and the third side wall 244 and the fourth side wall 245 are arranged opposite each other. The first side wall 242 has a first hole 2421, and a first conduit 201 extends through the first hole 2422. The second sidewall 243 is provided with a second hole 2432 through which the operating rod 260 extends, a third hole 2433 through which the second pipeline 202 extends, and a fourth hole 2434 through which the fourth pipeline 204 extends. The three-way valve 211 inside the infusion tank 240 is fixed to the first sidewall 242 by a three-way valve fixing bracket 2424.

[0041] In some embodiments, see Figures 2 to 4 The operating lever 260 includes a lever body 261 and a valve core connecting part 262, with the valve core connecting part 262 located at one end of the lever body 261. A three-way valve 211 within the infusion tank 240 has a knob 2112, and the valve core connecting part 262 has a coupling feature that engages with the knob 2112. The valve core connecting part 262 is located inside the infusion tank 240; the lever body 261 can extend through the second hole 2432 to the outside of the infusion tank 240. Medical personnel can manually rotate the operating lever 260 to rotate the valve core of the three-way valve 211 within the infusion tank 240. Optionally, the valve core connecting part 262 cannot pass through the second hole 2432, thereby limiting the range of axial movement of the operating lever 260.

[0042] The coupling feature of the valve core connecting portion 262 is configured as a connecting groove, with the end of the valve core connecting portion 262 away from the rod body 261 having a connecting groove suitable for accommodating the knob 2112. Optionally, the valve core connecting portion 262 is detachably connected to the rod body 261. Specifically, the rod body 261 is configured as a cylinder, the second hole 2434 is configured as a circular hole, the valve core connecting portion 262 is configured as a cylinder, and the radius of the valve core connecting portion 262 is larger than the radius of the second hole 2434.

[0043] The operating lever 260 also includes a limiting block 263, and the infusion tank 240 is provided with a limiting groove 2438. When the valve core connection part 262 is engaged with the knob 2112, the limiting block 263 is located within the limiting groove 2438 and restricts the rotation range of the operating lever 260. The limiting groove 2438 can restrict the operating lever 260 to rotate between a first rotation position, a second rotation position, and a third rotation position, thereby causing the valve core of the three-way valve 211 in the infusion tank 240 to switch between the first position, the second position, and the third position. That is, when the operating lever 260 is in the first rotation position, the valve core of the three-way valve 211 in the infusion tank 240 is in the first position; when the operating lever 260 is in the second rotation position, the valve core of the three-way valve 211 in the infusion tank 240 is in the second position; and when the operating lever 260 is in the third rotation position, the valve core of the three-way valve 211 in the infusion tank 240 is in the third position. Preferably, the limiting block 263 is located outside the infusion tank 240, and the limiting groove 2438 can also limit the axial movement of the operating rod 260.

[0044] Specifically, in some embodiments, the second sidewall 243 is provided with two stops, and a limiting groove 2438 is formed between the stops. In some embodiments, the portion of the second sidewall 243 adjacent to the second hole 2432 is removed to form the limiting groove 2438. See also Figure 3 and Figure 4 In some embodiments, the second sidewall 243 is provided with a limiting disc 2436, and the second hole 2432 is disposed in the middle of the limiting disc 2436. A limiting groove 2438 communicating with the second hole 2434 is provided on one side of the outer surface of the limiting disc 2436, and the limiting groove 2438 is defined by two sidewalls and a bottom wall located between the two sidewalls. The limiting disc 3436 is provided with a limiting step protruding from the outer surface of the second sidewall 243, and a limiting groove 2438 communicating with the second hole 2432 is formed between the two opposite sides of the limiting step. Alternatively, the limiting step of the limiting disc 3436 may also be flush with or lower than the outer surface of the second sidewall 243. When the bottom wall of the limiting groove 2438 contacts the limiting block 263, the operating rod 260 can be restricted from continuing to move toward the three-way valve 211 inside the infusion tank 240. Optionally, when the valve core connection 262 is engaged with the knob 2112, the bottom of the limiting groove 2438 contacts the limiting block 263.

[0045] Specifically, the operating lever 260 also includes a handle 264 disposed at the other end of the lever body 261. The handle 264 has anti-slip features, making the operating lever 260 easy to hold and rotate. Specifically, the anti-slip features are anti-slip stripes disposed circumferentially on the handle. Optionally, the operating lever 260 also has a baffle 265 located on the lever body 261 for convenient gripping and operation. Specifically, the baffle 265 is disposed on the side of the handle 264 near the valve core connection portion 262.

[0046] Specifically, a support seat 2442 is provided on the third side wall 244, and a through hole 2444 is provided on the support seat 2442. The rod 261 located in the infusion tank 240 extends through the through hole 2444, and the support seat 2442 is used to support the rod 261.

[0047] The procedure for delivering radioactive microspheres using the infusion system 200 is as follows: First, before connecting the tubing, air must be purged from each tubing. Then, manually operate the three-way valve 211 inside the infusion tank 240 to connect the first tubing 201 to the second tubing 202. Manually adjust the three-way valve 211 outside the infusion tank 240 to connect the first syringe 221 and the second syringe 222 sequentially to the second tubing 202, thereby injecting water for injection and contrast agent sequentially into the second tubing 201 to determine the surgical location. Next, manually operate the three-way valve 211 inside the infusion tank 240 to connect the first tubing 201 to the third tubing 203, injecting the water for injection from the third syringe 223 (connected to the fourth tubing 204) into the radiopharmaceutical product vial 40. The radioactive microspheres in the radiopharmaceutical product vial 40 are then delivered into the human body along with the water for injection through the third tubing 203 and the first tubing 201. During the microsphere infusion process, contrast agent needs to be frequently injected from the second syringe 222, and the operating procedure is the same as before. In addition, the third syringe 223 needs to draw in air and inject the air in the third syringe 223 into the radiopharmaceutical product bottle 40, so that all the remaining radioactive microspheres in the radiopharmaceutical product bottle 40 can be injected into the human body.

[0048] Specifically, the operation of delivering radioactive microspheres using the infusion system 200 includes five steps: purging air from the tubing, injecting contrast agent, injecting water for injection (i.e., injecting microspheres), injecting air (i.e., emptying the microspheres), and continuing to inject contrast agent. By first injecting water for injection and then injecting air, all the radioactive microspheres are pushed into the body. During the delivery process, steps two and three are repeated multiple times until the microspheres are almost completely delivered before proceeding to step four.

[0049] In step one, the three-way valve 211 located outside the infusion tank 240 is operated to connect the first syringe 221 to the tubing 202. The three-way valve 211 located inside the infusion tank 240 is operated to connect the second tubing 202 to the first tubing 201 or to the third tubing 203, thus injecting the first syringe 221 containing water for injection until all air in the tubing is expelled. In step two, the three-way valve 211 located outside the infusion tank 240 is operated to connect the second syringe 222 to the second tubing 202. The three-way valve 211 located inside the infusion tank 240 is operated to connect the second tubing 202 to the first tubing 201, thus pushing the contrast agent into the human body through the second syringe 222, the second tubing 202, and the first tubing 201. In the preparatory work before step three, both the first needle body 32 and the second needle body 34 are inserted below the liquid surface of the radiopharmaceutical product vial 40 used to store radioactive microspheres. The first needle body 32 is positioned 5 mm below the liquid surface, and the second needle body 34 is located at the bottom of the radiopharmaceutical product vial 40. In step three (microsphere injection), the three-way valve 211 located in the infusion tank 240 is operated to connect the third tubing 203 with the first tubing 201. Injection water is then injected into the radiopharmaceutical product vial 40 through the third syringe 223 and the fourth tubing 204, causing the radioactive microspheres in the vial 40 to rotate into a suspension. The microsphere mixture is then delivered to the human body through the third tubing 203 and the first tubing 201. During the delivery of the radioactive microspheres, contrast agent can be injected intermittently as needed to observe the arrival position of the radioactive microspheres. Steps two and three are repeated until the water for injection in the third syringe 223 is completely infused. At this point, most of the radioactive microspheres have been delivered to the human body, and only the radioactive microspheres remain at the bottom of the radiopharmaceutical product vial 40. The first needle body 32 is inserted into the bottom of the radiopharmaceutical product vial 40, and the second needle body 34 is inserted 5 mm below the liquid surface. Then, proceed to step four (emptying the microspheres). In step four, air is pushed into the radiopharmaceutical product vial 40 through the third syringe 223 and the fourth tubing 204. The air pressure pushes all the microsphere mixture at the bottom of the radiopharmaceutical product vial 40 into the first tubing 201, and then proceeds to step five. The three-way valve 211 located outside the infusion tank 240 is operated to connect the second syringe 222 to the second tubing 202. The three-way valve 211 located inside the infusion tank 240 is operated to connect the second tubing 202 to the first tubing 201. Contrast agent is injected through the second syringe 222, the second tubing 202 and the first tubing 201 to observe the arrival position of the radioactive microspheres.

[0050] The radioactive microspheres are radioactive. The radiopharmaceutical product vial 40 storing the radioactive microspheres is placed in the radiation shielding device 100 of the infusion system 200. The radiation shielding device 100 is located within the infusion tank 240, which reduces the radiation exposure of the radioactive microspheres to the operators. Furthermore, the radiation shielding device 100 secures the radiopharmaceutical product vial 40 within it, preventing damage to the vial 40 during transportation and transfer. Preferably, the infusion tank 240, the radiopharmaceutical product vial 40, the radiation shielding device 100, and all pipelines are constructed as transparent components. The main body of the radiation shielding device 100 is made of a transparent material, such as plexiglass, which offers high radiation protection. This allows medical personnel to easily monitor the microsphere delivery process during surgery.

[0051] The following reference Figures 5 to 16 The radiation protection device 100 disclosed herein is described in detail, wherein, Figures 5 to 9 This is one embodiment of the radiation protection device 100. Figures 10 to 16 This is another embodiment of the radiation shielding device 100. The radiation shielding device 100 disclosed herein is adapted to be used with a radiopharmaceutical product vial 40 in a radiopharmaceutical infusion system 200. The radiopharmaceutical product vial 40 includes a neck 42, a shoulder 44, and a body 46 connected sequentially from top to bottom in its height direction. The height direction of the radiopharmaceutical product vial 40 is along the axis of the radiopharmaceutical product vial 40.

[0052] Specifically, the radiation shielding device 100 of this disclosure includes a cover 10 and a shielding body 20. The cover 10 includes a cap 11 and a rod 12 extending downward from the cap 11. The lateral dimension of the cap 11 is larger than that of the rod 12. The rod 12 has an inner cavity suitable for accommodating a neck 42 and a portion of a shoulder 44 of a radiopharmaceutical product vial. The lower end of the rod 12 has a sloping inner wall 14; that is, the lower inner wall of the rod 12 is constructed as a slope. Specifically, in some embodiments, the cap 11 is constructed as a cylinder, and the rod 12 is constructed as a barrel. The outer diameter of the cap 11 is larger than the outer diameter of the rod 12; that is, the radial dimension of the cap 11 is larger than the radial dimension of the rod 12.

[0053] In some embodiments, see Figure 6 and Figure 8 The cap 10 has a stepped hole 112 in the middle, through which the first needle 32 and the second needle 34 can be inserted into the radiopharmaceutical product vial 40. In other embodiments, see... Figure 10 and Figure 14The cover 10 has a protrusion 114 in the middle, with a first puncture hole 15 and a second puncture hole 16. The first puncture hole 15 is suitable for guiding the first needle 32 into the radiopharmaceutical product vial 40, i.e., the first needle 32 is inserted into the radiopharmaceutical product vial 40 through the first puncture hole 15. The second puncture hole 16 is suitable for guiding the second needle 24 into the radiopharmaceutical product vial 40, i.e., the second needle 34 is inserted into the radiopharmaceutical product vial 40 through the second puncture hole 16. The diameters of the first puncture hole 15 and the second puncture hole 16 are adapted to the outer diameters of the first needle 32 and the second needle 24, so that when the first needle 32 and the second needle 24 are inserted into the first puncture hole 15 and the second puncture hole 16, they fit tightly against their corresponding first puncture holes 15 and second puncture holes 16. Figures 6 to 8 Implementation examples, Figure 10 and Figure 14 In this embodiment, the radioactivity of the radiopharmaceutical can be further shielded. Preferably, the axis of the first puncture hole 15 is located at the center of the cap 10, so that the first needle 32 can be inserted into the center of the radiopharmaceutical product vial 40 (V-shaped vial), thereby ensuring that all radioactive microspheres can be pushed into the human body through the first needle 32. Preferably, the distance between the first puncture hole 15 and the second puncture hole 16 is ≥2mm, which can prevent the first needle 32 and the second needle 34 from being too close during the puncture process, thereby causing the rubber stopper of the radiopharmaceutical product vial 40 to be torn and causing leakage.

[0054] Specifically, the shielding body 20 has an opening at its upper end and a bottom wall 202 at its lower end. See also the following embodiments: Figure 7 The shielding body 20 includes a joint 21 in the upper section and a receiving section 22 in the lower section. The joint 21 is used to engage and lock with the cap 10, and the opening of the shielding body 20 is provided in the joint 21. The receiving section 22 is used to receive the radiopharmaceutical product vial 40. Specifically, the joint 21 has a channel extending in the height direction, which communicates with the receiving section 22. The channel is configured to allow the radiopharmaceutical product vial 40 and the rod 12 to pass through and enter the receiving section 22. Specifically, the receiving section 22 is configured as a barrel shape, having an inner sidewall 224. The bottom wall 202 of the shielding body 20 and the inner sidewall 224 define the receiving space of the receiving section 22.

[0055] Specifically, one of the cap 10 and the shielding body 20 is provided with a wedge-shaped protrusion 13, and the other is provided with a groove 24 suitable for engaging the wedge-shaped protrusion 13. The wedge-shaped protrusion 12 or the groove 24 provided on the cap is located on the outer periphery of the rod portion 12, and the wedge-shaped protrusion 13 or the groove 24 provided on the shielding body 20 is located at the joint portion 21. When the radiopharmaceutical product vial 40 is placed in the receiving portion 22 and the cap 10 and the shielding body 20 are tightened by the wedge-shaped protrusion 13 and the groove 24, the sloping inner wall 14 abuts against the shoulder portion 44 of the radiopharmaceutical product vial 40. The wedge-shaped protrusion 13 has an inclined upper surface 131, which slopes downward along the tightening direction. The groove 24 has an inclined mating surface 231, which is configured to engage with the upper surface 131 of the wedge protrusion 13 such that when the wedge protrusion 13 and the groove 24 are tightened, the mating surface 231 at least partially abuts against the upper surface 131 of the wedge protrusion 13.

[0056] In some embodiments, the cover 10 is provided with a groove 24, and the shielding body 20 is provided with a wedge-shaped protrusion 13. Specifically, the cover 10 also includes a tube extending downward from the cap portion 11, the tube being coaxially arranged with the rod portion 12 and located outside the rod portion 12, and the groove 24 being provided on the inner sidewall of the tube. The outer periphery of the joint portion 21 is provided with a wedge-shaped protrusion 13, which is configured to slide in the groove 24.

[0057] In other embodiments, see Figures 5 to 7 ,as well as Figures 10 to 13 The cover 10 is provided with a wedge-shaped protrusion 13, and the shielding body 20 is provided with a sliding groove 24. Specifically, the wedge-shaped protrusion 13 is connected to the outer wall of the rod portion 11, and the sliding groove 24 is provided on the inner wall 224 of the joint portion 21. In some embodiments, when viewed from above, the tightening direction of the radiation shielding device 100 can be either clockwise or counterclockwise. The following description uses the clockwise direction as an example. Specifically, the upper surface 131 of the wedge-shaped protrusion 13 and the mating surface 231 of the sliding groove 24 are both inclined from top to bottom in a clockwise direction. Optionally, the lower surface 132 of the wedge-shaped protrusion 13 is constructed as a plane, for example, a plane parallel to the horizontal plane. The sliding groove 24 has a mating surface 231, a circumferential side surface, and a limiting surface 248, which is constructed as a plane parallel to the lower surface of the wedge-shaped protrusion 13. In some embodiments, the limiting surface 248 limits the maximum travel of the wedge-shaped protrusion 13 within the groove 24, and the wedge-shaped protrusion 13 cannot continue to slide within the groove 24 when the lower surface 132 of the wedge-shaped protrusion 13 contacts the limiting surface 248. In other embodiments, the wedge-shaped protrusion 13 cannot continue to move within the groove 24 when it moves within the groove 24 to the point where the bottom wall of the cap 11 abuts against the upper wall of the joint 21.

[0058] More specifically, a wedge-shaped stop 23 is provided on the inner periphery of the joint 21, and the lower surface of the wedge-shaped stop 23 is the mating surface 231 of the groove 24. Optionally, a groove 24 for engaging the wedge-shaped protrusion 13 is formed between the receiving portion 22 and the wedge-shaped stop 23. In some embodiments, the top surface of the receiving portion 22 constitutes the limiting surface 248 of the groove 24. Specifically, the inner sidewall of the joint 21 is the circumferential side surface of the groove 24, and the top surface of the receiving portion 22 is the limiting surface 248 of the groove 24, that is, the groove 24 is defined by the mating surface 231 of the wedge-shaped stop 23, the top surface of the receiving portion 22, and the inner sidewall of the joint 21.

[0059] See Figure 6 and Figure 7 Two wedge-shaped protrusions 13 are constructed, and the two wedge-shaped protrusions 13 are evenly spaced circumferentially. The joint 21 has two notches 212 communicating with the channel of the joint 21, and the two notches 212 are symmetrically arranged. Two grooves 24 are constructed, and the two grooves 24 are respectively located between the two notches 212. Each notch 212 is configured to allow one wedge-shaped protrusion 13 to pass through, and the wedge-shaped protrusion 13 enters the groove 24 from the notch 212. Specifically, the shape of the notch 212 can be arbitrary, as long as it satisfies the requirement that the wedge-shaped protrusion 13 can enter the groove 24 from the notch 212. Specifically, two wedge-shaped stops 23 are constructed, and the two wedge-shaped stops 23 are evenly spaced circumferentially, and the two wedge-shaped stops 23 radially enclose the channel of the joint 21. See also... Figure 8 and Figure 9 The radial dimensions of the channel of the joint 21 and the receiving part 22 are adapted to the radial dimensions of the rod 12. The rod 12 can pass through the channel and extend into the receiving part 22. The gap between the rod 12 and the wedge-shaped stop 23 and the receiving part 22 is small or close, which can prevent the cover 10 from shaking relative to the shielding body 20 in the radial direction, thereby helping to prevent the radiopharmaceutical product bottle 40 from shaking in the shielding body 20.

[0060] When the cap 10 aligns with the shielding body 20, the wedge-shaped protrusion 13 can slide along the groove 24 until it at least partially abuts against the wedge-shaped stop 23, thereby locking the cap 10 and the shielding body 20 together. Because the lower inner wall of the rod 12 is constructed in a sloping shape, when the cap 10 and the shielding body 20 are locked together, the sloping inner wall 14 abuts against the shoulder 44 of the radiopharmaceutical product vial 40, and the cap 10 and the shielding body 20 are tightly fitted radially. Therefore, the radiopharmaceutical product vial 40 is fixed both radially and vertically. During transfer, the radiopharmaceutical product vial 40 will not shake within the radiation protection device 100, thus preventing rupture and leakage of radionuclides due to shaking. The abutment of the sloping inner wall 14 against the shoulder 44 of the radiopharmaceutical product vial 40 also prevents the surgeon from lifting the radiopharmaceutical product vial 40 within the protective device when inserting or removing the first needle 32 and the second needle 34 during surgery, thus preventing any impact on the surgeon's operating speed.

[0061] Preferably, in some embodiments, see Figures 6 to 9 The angle between the radially extending line from top to bottom on the upper surface 131 of the wedge-shaped protrusion 13 and the horizontal plane located in the middle of the wedge-shaped protrusion 13 transitions from α° to -α°, where α° is greater than 0°. The radially extending line refers to the boundary line between the radial section of the cover 10 and the upper surface 131 of the wedge-shaped protrusion 13. The mating surface 231 is constructed to align with the upper surface 131 of the wedge-shaped protrusion 13. The viewing direction is from the lower end of the wedge-shaped protrusion 13 towards the upper end.

[0062] When the radiation shielding device 100 accommodates the V-shaped bottle, and the cap 10 and the shielding body 20 are tightened by the wedge-shaped protrusion 13 and the slide groove 24, the wedge-shaped protrusion 13 can partially slide into the slide groove 24, fully slide into the slide groove 24, or partially slide out of the slide groove 24. Since the angle between the radial extension line of the upper surface 131 of the wedge-shaped protrusion 13 arranged from top to bottom and the horizontal plane transitions from α° to -α°, and the mating surface 231 is constructed to be consistent with the upper surface 131 of the wedge-shaped protrusion 13, when the lower end of the wedge-shaped protrusion 13 slides into the upper end of the slide groove 24, the distance between the outer edge of the upper surface 131 and the outer edge of the mating surface 231 is relatively large, while the inner edge of the upper surface 131 abuts against the inner edge of the mating surface 231. This allows the wedge-shaped protrusion 13 to be locked in place at any position by abutting against the inner edge of the mating surface 231 with the inner edge of the upper surface 131 when it partially slides into the groove 24. This enables the radiation shielding device 100 to fix V-shaped bottles of different heights, such as V-shaped bottles of different sizes (5ml, 10ml, etc.) or V-shaped bottles of the same size within different height deviation ranges. In addition, since the upper surface 131 of the wedge-shaped protrusion 13 does not make large-area contact with the mating surface 231 of the groove 24 before it slides into the groove 24 and is not locked (at most, only the inner edge of the upper surface 131 contacts the inner edge of the mating surface 231), and the lower surface 132 of the wedge-shaped protrusion 13 does not contact the lower surface of the groove 24, the friction between the two is small during relative movement, making it easy for the operator to quickly tighten the cap 10. During the tightening process, the rod 12 moves rapidly downward in a spiral motion along with the cap 10, causing the V-shaped bottle located in the shielding body 20 to engage with the rod 12 while remaining stationary, until the sloping inner wall 14 of the rod 12 abuts against the shoulder 44.

[0063] When the wedge-shaped protrusion 13 is fully slid into the groove 24 and the sloping inner wall 14 just abuts against the shoulder 44, the upper surface 131 of the wedge-shaped protrusion 13 is locked in place with the mating surface 231, that is, the upper surface 131 of the wedge-shaped protrusion 13 and the mating surface 231 are completely overlapped and aligned. When the wedge-shaped protrusion 13 partially slides out of the groove 24 and the sloping inner wall 14 abuts against the shoulder 44, for example, when the high end of the wedge-shaped protrusion 13 slides into the low end of the groove 24, the distance between the inner edge of the upper surface 131 and the inner edge of the mating surface 231 is relatively large, while the outer edge of the upper surface 131 abuts against the outer edge of the mating surface 231. This allows the wedge-shaped protrusion 13 to be locked in place at any position by abutting against the outer edge of the mating surface 231 when it partially slides out of the groove 24. In summary, when the wedge-shaped protrusion 13 of this disclosure is used to lock the slide groove 24, the wedge-shaped protrusion 13 can be locked at any position within the stroke range of partially sliding into the slide groove 24 to partially sliding out of the slide groove 24. Furthermore, the friction between the two during relative movement is small, allowing for quick tightening. This makes it easier for the sloping inner wall 14 of the rod 12 to abut against the shoulder 44 of the V-shaped bottle, and the V-shaped bottle is less likely to break during the fixing process.

[0064] See Figure 8 When the radiation shielding device 100 contains a 5ml V-shaped bottle, and the cap 10 and the shielding body 20 are tightened via the wedge-shaped protrusion 13 and the sliding groove 24, the upper surface 131 of the wedge-shaped protrusion 13 is fitted and locked to the mating surface 231, meaning the upper surface 131 of the wedge-shaped protrusion 13 and the mating surface 231 are completely overlapped and aligned. See also Figure 9 When the radiation shielding device 100 contains a 10ml V-shaped bottle, and the cap 10 and the shielding body 20 are tightened by the wedge-shaped protrusion 13 and the sliding groove 24, the inner edge of the upper surface 131 abuts and locks with the inner edge of the mating surface 231.

[0065] It should be added that the number of wedge-shaped protrusions 13 and wedge-shaped stops 23 can be configured as one or two, or as three or more, which can be adaptively adjusted based on the previous embodiments. Preferably, two wedge-shaped protrusions 13 and two wedge-shaped stops 23 are each configured.

[0066] The radiation shielding device 100 of this disclosure locks the cover 10 and the shielding body 20 together through the cooperation of the wedge-shaped protrusion 13 and the wedge-shaped stop 23. Due to the wedge-shaped locking structure, the locking process is less strenuous and can be locked at any position throughout the entire stroke. Moreover, compared with the threaded structure, it can be locked quickly. The lower end of the inner wall of the rod 12 is constructed into a slope to prevent the radiopharmaceutical product bottle 40 from shaking and breaking during the transfer process within the radiation shielding device 100. The radiation shielding device 100 of this disclosure can secure the radiopharmaceutical product bottle without damage and quickly, thereby reducing the radiation exposure to medical personnel during the process of securing the radiopharmaceutical product bottle to the radiation shielding device.

[0067] In other embodiments, see Figure 12 and Figure 13 In addition to a cover 10 with a wedge-shaped protrusion 13 or a sliding groove 24 and a shielding body 20, the radiation shielding device 100 also includes an inner liner 27 that can move along the height direction, and a V-shaped bottle is placed inside the inner liner 27. Because the inner liner 27 can move along the height direction, the radiation shielding device 100 is suitable for accommodating V-shaped bottles of different sizes, such as at least 5ml or 10ml V-shaped bottles, even when the engagement stroke of the wedge-shaped protrusion 13 and the sliding groove 24 is relatively short.

[0068] Specifically, the shielding body 20 includes a joint 21 in the upper section and an inner liner movable part 25 in the lower section. The joint 21 is used to engage and lock with the cap 10, and the inner liner movable part 25 provides space for the inner liner 27 to move. Specifically, the inner liner movable part 25 is constructed in a barrel shape, and the bottom wall 202 of the shielding body 20 forms the bottom of the inner liner movable part 25. The inner liner 27 and the first elastic member 28 are both disposed in the inner liner movable part 25, and the first elastic member 28 causes the inner liner 27 to tend to move away from the bottom of the inner liner movable part 25. The channel located in the joint 21 is constructed to allow the radiopharmaceutical product bottle 40 and the rod 12 to enter the inner liner 27 through it. Similarly, when the radiopharmaceutical product bottle 40 is placed in the inner liner 27 and the cap 10 and the shielding body 20 are tightened by the wedge-shaped protrusion 13 and the groove 24, the sloping inner wall 14 of the rod 12 abuts against the shoulder 44 of the radiopharmaceutical product bottle 40.

[0069] Specifically, the first elastic element 28 can be configured as a spring. The first elastic element 28 can be disposed at the bottom of the inner liner 27, for example, between the bottom of the inner liner 27 and the bottom of the inner liner movable part 25, i.e., the upper end of the first elastic element 28 is connected to the bottom of the inner liner 28, and the lower end is connected to the bottom of the inner liner movable part 25; the first elastic element 28 can also be disposed at the top or waist of the inner liner 27, for example, the upper end of the first elastic element 28 is connected to the upper part or the middle inner side of the shielding body 20, and the lower end is connected to the top or waist of the inner liner 27, so that the inner liner 27 is suspended in the inner liner movable part 25 by the first elastic element 28. The following description uses the example of the first elastic element 28 being disposed between the bottom of the inner liner 27 and the bottom of the inner liner movable part 25.

[0070] In some embodiments, an annular flange 26 protruding towards the inner side of the shielding body 20 is provided between the joint 21 and the inner liner movable part 25. The annular flange 26 is used to restrict the upward movement of the inner liner 27. In this case, the upper surface of the annular flange 26 is the limiting surface 248 of the groove 24, that is, the groove 24 is defined by the mating surface 231 of the wedge-shaped stop 23, the top surface of the annular flange 26, and the inner wall of the joint 21. In some embodiments, when the lower surface 132 of the wedge-shaped protrusion 13 contacts the limiting surface 248, the wedge-shaped protrusion 13 cannot continue to slide within the groove 24. See also Figure 15 and Figure 16 The radial dimension of the channel formed by the radial enclosure of several wedge-shaped blocks 23 and the radial dimension of the annular flange 26 are adapted to the radial dimension of the rod 12. The rod 12 can pass through the channel and extend into the annular flange 26. The gap between the rod 12 and the wedge-shaped blocks 23 and the annular flange 26 is small or close, so that the gap between the rod 12 of the cover 10 and the shielding body 20 is small or close in the radial direction, preventing the cover 10 from shaking relative to the shielding body 20 in the radial direction, thereby helping to prevent the radiopharmaceutical product bottle 40 from shaking in the shielding body 20.

[0071] Alternatively, in some embodiments, one or more protrusions protruding toward the inside of the shielding body 20 are provided between the joint 21 and the inner liner movable part 25, and the protrusions have the same function as the annular flange 26.

[0072] Specifically, the inner diameter of the inner liner 27 is configured to accommodate various sizes of radiopharmaceutical product vials 40. The outer diameter of the inner liner 27 is larger than the inner diameter of the annular flange 26, thus restricting the movement of the inner liner 27 within the inner liner movable portion 25. Under external force, the first elastic member 28 can be compressed in the height direction, allowing the inner liner 27 to move along the height direction within the inner liner movable portion 25. The height-direction movement distance of the inner liner 27 is configured to allow the radiation shielding device 100 to accommodate radiopharmaceutical product vials of different heights. Preferably, the first elastic member 28 is configured to accommodate various heights of radiopharmaceutical product vials, for example, at least 5ml and 10ml radiopharmaceutical product vials. The height-direction movement distance of the inner liner 27 is related to the compressibility distance of the first elastic member 28 and the internal height of the inner liner movable portion. In some embodiments, the upper surface of the annular flange 26 is configured such that when the wedge-shaped protrusion 13 is fully screwed into the groove 24, the upper surface of the annular flange 26 contacts the lower surface 132 of the wedge-shaped protrusion 13. During the process of placing the radiopharmaceutical product vial 40 into the inner liner 27 and tightening the cap 10 to the shielding body 20, the descending rod 12 causes the ramped inner wall 14 to abut against the shoulder 44 of the radiopharmaceutical product vial 40. After the ramped inner wall 14 abuts against the shoulder 44 of the radiopharmaceutical product vial 40, the rod 12 continues to descend, compressing the first elastic member 28. When the wedge-shaped protrusion 13 is fully screwed into the groove 24, the upper surface 131 of the wedge-shaped protrusion 13 abuts against the mating surface 231 of the groove 24, and the lower surface 132 of the wedge-shaped protrusion 13 abuts against the upper surface of the annular flange 26, preventing the wedge-shaped protrusion 13 from continuing to move in the tightening direction. This causes the rod 12 to stop moving, completing the locking of the cap 10 and the shielding body 20. In this embodiment, when the radiopharmaceutical product bottle 40 is placed inside the inner liner 27 and the cap 10 and the shielding body 20 are locked, the wedge-shaped protrusion 13 is just fully screwed into the groove 24. Therefore, when using the radiation protection device 100 of this disclosure to fix radiopharmaceutical product bottles 40 of different heights, the operator can quickly and easily determine whether they are tightened properly during the fixing process, which helps to reduce operation time. At the same time, since the downward stroke of the rod 12 is limited, it also avoids damage to the radiopharmaceutical product bottle 40 due to excessive torque applied by the operator.

[0073] When the external force applied to the first elastic element is released, the first elastic element can be raised to its initial height, so that the inner liner 27 is in its initial height position. See details below. Figure 12 and Figure 13 The first elastic element 28 is configured as a base spring, which includes four spring coils extending in the height direction and evenly distributed at intervals on the bottom of the inner liner movable portion 25. When the first elastic element 28 is disposed on the bottom of the inner liner 27, alternatively, the first elastic element 28 may also be configured as base rubber, base sponge, or a combination of at least two of them.

[0074] In some embodiments, one of the outer sidewall of the inner liner 27 and the inner sidewall of the inner liner movable part 25 is provided with a groove extending in the height direction, and the other is provided with a protrusion extending in the height direction, the groove and the protrusion engaging; when the inner liner 27 moves relative to the shielding body 20 in the height direction, one of the groove and the protrusion slides relative to the other. The groove and the protrusion can be used to guide the movement of the inner liner 27 in the height direction. Figure 12 and Figure 13 In the illustrated embodiment, the inner wall of the movable inner liner 25 is provided with a protrusion 251, and the outer wall of the inner liner 27 is provided with a groove 271. Alternatively, in some other embodiments, the groove is provided on the inner wall of the movable inner liner 25, and the protrusion is provided on the outer wall of the inner liner 27.

[0075] exist Figures 10 to 16 In the illustrated embodiment, the inner liner 27 has a plurality of circumferentially spaced rotating shafts 272 and movable feet 273 on its inner side. Each movable foot 273 has a fixed end 2731 and a free end 2732, and the fixed end 2731 of each movable foot 273 is rotatably connected to the inner liner 27 via a rotating shaft 272. The radiation shielding device 100 also includes a plurality of second elastic elements 272, each second elastic element 272 being coupled to a movable foot 273 so that the free end of the movable foot 273 connected thereto tends to be close to the axis of the inner liner 27. That is, the plurality of second elastic elements 272 tend to bring the free ends of the plurality of movable feet 273 together, which facilitates the clamping of V-shaped bottles with different outer diameters of the fixed bottle body 46 by the movable feet 273, so that the V-shaped bottles are more reliably fixed. Specifically, the movable feet 273 can be configured to be 2 to 6. Figure 13 In the embodiment shown, four movable feet 273 are configured, and the four movable feet 273 are circumferentially equidistantly arranged in the inner liner 27.

[0076] Specifically, the inner wall of the inner liner 27 is provided with a plurality of accommodating grooves 275 arranged circumferentially, and a rotating shaft 272 is disposed in each accommodating groove 275. In some embodiments, the rotating shaft 272 is rotatably fixed to the inner liner 27, and the fixed end 2731 of the movable foot 273 is fixed to the rotating shaft 272. Specifically, for example, the groove wall of the accommodating groove 275 is provided with a hole, and the rotating shaft 272 extends into the hole in the groove wall so that the rotating shaft 272 can rotate. The second elastic element 272 can be configured as a torsion spring, one end of the torsion spring is fixed to the inner liner 27, and the other end of the torsion spring is fixed to the rotating shaft 272 or the movable foot 273. The torsion spring causes the free end of the movable foot 273 connected to it to tend to approach the axis of the inner liner 27.

[0077] In other embodiments, see Figure 12 , Figure 13The rotating shaft 272 is fixed to the inner liner 27, and the movable foot 273 is rotatably connected to the rotating shaft 272. For example, the fixed end 2731 of the movable foot 273 has a laterally extending rotating shaft hole 2733, through which the rotating shaft 272 extends, thereby rotatably fixing the movable foot 273 to the inner liner 27. The second elastic element 272 is constructed as a coil spring, which is disposed between the groove wall of the receiving groove 275 and the movable foot 273. The coil spring causes the free end of the movable foot 273 connected thereto to tend to approach the axis of the inner liner 27.

[0078] See Figure 12 In its natural state, the free end 2732 of the movable foot 273 protrudes from the inner wall of the inner liner 27. Under the action of external force, the movable foot 273 can rotate around the rotation axis 272, causing the free end 2732 of the movable foot 273 to move towards the inner wall of the inner liner 27. In some embodiments, the movable foot 273 can be completely embedded in the receiving groove 275. In some embodiments, see Figure 13 The receiving groove 275 is provided with a spring hole 276, and the movable foot 273 is also provided with a spring hole 276 in the middle of the side away from the axis of the inner liner 27. One end of the helical spring is connected to the spring hole 276 in the middle of the movable foot 273, and the other end is connected to the spring hole 276 in the receiving groove 275. In its natural state, the helical spring provides support for the free end 2732 of the movable foot 273 protruding from the inner wall of the inner liner 27. When an outward force is applied to the free end 2732 of the movable foot 273, the helical spring is compressed under the action of the external force, causing the free end 2732 of the movable foot 273 to move closer to the inner wall of the inner liner 27. The movable foot 273 and the helical spring are configured such that the range of motion of the movable foot 273 can provide clamping and fixing for radiopharmaceutical product vials 40 of various radial dimensions.

[0079] In a preferred embodiment, both the second elastic element 272 and the first elastic element 28 are configured such that their respective elastic deformations are compatible with at least two different sizes of radiopharmaceutical product vials 40. When the inner liner 27 contains radiopharmaceutical product vials 40 of different sizes, the degree of elastic deformation of the second elastic element 272 and the first elastic element 28 is different.

[0080] The radiation protection device 100 with movable feet 273 on the inner liner 27 can fix the radiopharmaceutical product bottles 40 of various specifications with different radial dimensions in the middle of the inner liner 27 when loading them, and prevent the radiopharmaceutical product bottles 40 from shaking radially.

[0081] In some embodiments, specifically, see Figure 14 and Figure 15When the radiation protection device 100 is loaded with a 5ml V-shaped vial 402, the free end 2732 of the movable foot 273 abuts against the body 46 of the 5ml V-shaped vial 402 to center it in the inner liner. The second elastic member 272 provides a pushing (clamping) force to the body 46 of the vial for the free end 2732. The V-shaped vial is centered in the inner liner, so that during the operation, when the doctor inserts the first needle body 32 and the second needle body 34 into the radiation protection device 100 through the first puncture hole 15 or the second puncture hole 16, the first needle body 32 and the second needle body 34 can be accurately inserted into the rubber stopper of the radiopharmaceutical product vial 40, and the first needle body 32 can be aligned with the center of the radiopharmaceutical product vial 40.

[0082] See Figure 16 When the radiation shielding device 100 is loaded with a 10ml V-shaped vial 404, the free end 2732 of the movable leg 273 is fully embedded in the receiving groove 275. It should be noted that in other embodiments, when the radial dimension of the inner liner 27 is configured to be greater than the outer diameter of the 10ml V-shaped vial 404, the free end 2732 of the movable leg 273 may not be fully embedded in the receiving groove 275 when the radiation shielding device 100 is loaded with a 10ml V-shaped vial 404. The free end 2732 of the movable leg 273 abuts against the body portion 46 of the 10ml V-shaped vial 404 to centrally position it within the inner liner, and the second elastic member 272 provides a pushing (clamping) force to the body portion 46 of the free end 2732. This type of radiation shielding device 100 is not limited to loading 5ml V-shaped vials 402 and 10ml V-shaped vials 404; it can also load other sizes of radiopharmaceutical product vials 40.

[0083] The following uses a 5ml V-shaped bottle of 402 as an example to introduce... Figures 10 to 16 The method of loading the V-shaped bottle into the radiation shielding device 100 shown.

[0084] First, place the 5ml V-shaped bottle 402 on the four movable feet 273 of the inner liner 27. Use the rod 12 of the cap 10 to fit over the outside of the rubber stopper at the neck 42 of the 5ml V-shaped bottle 402, with the sloping inner wall 14 aligned with the shoulder 44 of the V-shaped bottle. Then, use the cap 10 to press the 5ml V-shaped bottle 402 vertically downwards. The 5ml V-shaped bottle 402 presses the movable feet 273, causing the movable feet 273 to rotate around the rotating axis 272. The free ends of the movable feet 273 move towards the receiving groove 275. When the 5ml V-shaped bottle 402 contacts the bottom of the inner liner 27, the four movable feet 273 are pressed towards the center under the elastic force of the second elastic element 272. The free ends of the four movable feet 273 tightly press against the 5ml V-shaped bottle 402, ensuring that the 5ml V-shaped bottle 402 remains in the center. Once the 5ml V-shaped bottle 402 contacts the bottom of the inner liner 27, the cap 10 continues to press the 5ml V-shaped bottle 402 vertically downwards, thereby pushing the inner liner 27 downwards. This causes the first elastic element 28 to be compressed and shortened until the wedge-shaped protrusion 13 of the cap 10 enters the slide groove 24 through the notch 212. Then, the cap 10 is rotated clockwise so that the wedge-shaped protrusion 13 is fully screwed into the slide groove 24, and the wedge-shaped protrusion 13 and the wedge-shaped stop 23 are aligned, locking the cap 10 and the shielding body 20. At this time, the sloping inner wall 14 abuts against the shoulder 44 of the V-shaped bottle, and the four movable feet 273 clamp and fix the bottle body 46 of the V-shaped bottle, completing the fixation of the V-shaped bottle.

[0085] use Figures 10 to 16 When the radiation shielding device 100 is loaded with V-shaped bottles of different sizes, the first elastic element 28 is compressed to different degrees, and the wedge-shaped protrusion 13 can be fully screwed into the slide groove 24. In addition, the radiation shielding device 100 can accommodate various sizes of V-shaped bottles while ensuring stable placement of the V-shaped bottles.

[0086] The above descriptions are merely a few embodiments of this disclosure. Those skilled in the art can make various modifications or variations to the embodiments of this disclosure based on the content disclosed in the application documents without departing from the spirit and scope of this disclosure.

Claims

1. A radiation shielding device for fitting to a radiopharmaceutical product vial in a radiopharmaceutical infusion system, the radiopharmaceutical product vial including a neck portion, a shoulder portion, and a body portion coupled in that order from top to bottom in a height direction thereof; characterized in that, The radiation protection device comprises: a cover body comprising a cap portion and a stem portion extending downward from the cap portion, the cap portion having a transverse dimension greater than that of the stem portion, the stem portion being provided with an inner cavity adapted to accommodate a neck and a part of a shoulder of the radiopharmaceutical product bottle, and a lower end of the stem portion being provided with a ramp-shaped inner wall; and a shielding body comprising an engaging portion engaged with the cover body and an accommodating portion accommodating the radiopharmaceutical product bottle, the engaging portion being provided with a passage extending in a height direction, the passage being configured to be adapted for the radiopharmaceutical product bottle and the stem portion to pass therethrough into the accommodating portion; wherein one of the cover body and the shielding body is provided with a wedge-shaped protrusion, and the other is provided with a sliding groove adapted to engage the wedge-shaped protrusion, the wedge-shaped protrusion or the sliding groove provided on the cover body being located at an outer periphery of the stem portion, and the wedge-shaped protrusion or the sliding groove provided on the shielding body being located at the engaging portion; when the radiopharmaceutical product bottle is placed in the accommodating portion and the cover body and the shielding body are screwed together through the wedge-shaped protrusion and the sliding groove, the ramp-shaped inner wall abuts against the shoulder of the radiopharmaceutical product bottle.

2. The radiation protection device according to claim 1, wherein the wedge-shaped protrusion has an inclined upper surface, the upper surface of the wedge-shaped protrusion being inclined downward from top to bottom in a screwing direction; the sliding groove has an inclined matching surface adapted to match the upper surface of the wedge-shaped protrusion so that the matching surface at least partially abuts against the upper surface of the wedge-shaped protrusion when the wedge-shaped protrusion and the sliding groove are screwed together.

3. The radiation protection device of claim 2, wherein, the wedge-shaped protrusion is provided on the cover body and connected to an outer side wall of the stem portion, and the sliding groove is provided on an inner side wall of the engaging portion of the shielding body.

4. The radiation protection device of claim 3, wherein, an included angle between a radially extending line arranged from top to bottom on the upper surface of the wedge-shaped protrusion and a horizontal plane transitions from a to -a, a being greater than 0°; wherein the radially extending line refers to an intersection line between a radial section of the cover body and the upper surface of the wedge-shaped protrusion, the matching surface is configured to be consistent with the upper surface of the wedge-shaped protrusion.

5. The radiation protection device of claim 3, wherein, the wedge-shaped protrusion is configured as two wedge-shaped protrusions, the two wedge-shaped protrusions being uniformly and circumferentially spaced apart; the engaging portion is provided with two notches in communication with the passage of the engaging portion, the two notches being symmetrically arranged, and the sliding groove is configured as two sliding grooves, the two sliding grooves being respectively located between the two notches; wherein each notch is configured to be adapted for one wedge-shaped protrusion to pass therethrough.

6. The radiation protection device of claim 5, wherein, the engaging portion comprises two wedge-shaped stop blocks provided on the inner side wall thereof, a lower surface of the wedge-shaped stop block being the matching surface of the sliding groove, and the two wedge-shaped stop blocks are radially enclosed to form the passage; a radial dimension of the stem portion is adapted to radial dimensions of the passage and the accommodating portion, so that the outer side wall of the stem portion is in abutment with the wedge-shaped stop blocks and the inner side wall of the accommodating portion.

7. The radiation protection device of claim 3, wherein, a height of a travel of the wedge-shaped protrusion and the sliding groove in cooperation is greater than or equal to a height difference of two different height specifications of the radiopharmaceutical product bottle.

8. The radiation protection device according to any one of claims 1 to 7, characterized in that the radiopharmaceutical infusion system comprises a first needle body and a second needle body; The cover is provided with a first puncture hole and a second puncture hole, the first puncture hole is suitable for guiding the first needle body to enter the radioactive drug product bottle, and the second puncture hole is suitable for guiding the second needle body to enter the radioactive drug product bottle. The first needle body is used for delivering the drug in the radioactive drug product bottle to the lesion position of the patient, and the second needle body is used for injecting gas or injection water into the radioactive drug product bottle.

9. The radiation protection device of claim 8, wherein, The first puncture hole and the second puncture hole are both arranged on the cap part, the first puncture hole is located at the central part of the cap part, and the distance between the first puncture hole and the second puncture hole is greater than or equal to 2 mm.

10. A radiopharmaceutical infusion system, characterized by, The infusion box, the flow channel, the three-way valve arranged on the flow channel, the first needle body, the second needle body, and the radiation protection device according to any one of claims 1-7 are included, the first needle body and the second needle body are in fluid communication with the radioactive drug product bottle, and the radiation protection device and the three-way valve are arranged in the infusion box. The flow channel includes a first pipeline, a second pipeline, a third pipeline, and a fourth pipeline, three ends of the three-way valve are connected with the first pipeline, the second pipeline, and the third pipeline respectively, and the fourth pipeline is in fluid communication with the radioactive drug product bottle through the second needle body, wherein the other end of the first pipeline is connected with the human body, the second pipeline is used for delivering injection water or a contrast medium to the human body, the other end of the third pipeline is connected with the radioactive drug product bottle through the first needle body, and the fourth pipeline is used for injecting gas or injection water into the radioactive drug product bottle. The three-way valve is controlled to selectively connect any two of the first pipeline, the second pipeline, and the third pipeline.